CA2507511A1 - Ester combination local anesthetic - Google Patents

Ester combination local anesthetic Download PDF

Info

Publication number
CA2507511A1
CA2507511A1 CA002507511A CA2507511A CA2507511A1 CA 2507511 A1 CA2507511 A1 CA 2507511A1 CA 002507511 A CA002507511 A CA 002507511A CA 2507511 A CA2507511 A CA 2507511A CA 2507511 A1 CA2507511 A1 CA 2507511A1
Authority
CA
Canada
Prior art keywords
anesthetics
ester
anesthesia
anesthetic
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002507511A
Other languages
English (en)
French (fr)
Inventor
Steven L. Shafer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2507511A1 publication Critical patent/CA2507511A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002507511A 2002-12-20 2003-12-18 Ester combination local anesthetic Abandoned CA2507511A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32731002A 2002-12-20 2002-12-20
US10/327,310 2002-12-20
PCT/US2003/041219 WO2004058329A2 (en) 2002-12-20 2003-12-18 Ester combination local anesthetic

Publications (1)

Publication Number Publication Date
CA2507511A1 true CA2507511A1 (en) 2004-07-15

Family

ID=32680753

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002507511A Abandoned CA2507511A1 (en) 2002-12-20 2003-12-18 Ester combination local anesthetic

Country Status (10)

Country Link
EP (1) EP1572218A4 (de)
JP (1) JP2006513224A (de)
KR (1) KR20050085736A (de)
CN (1) CN1729004A (de)
AU (1) AU2003299885A1 (de)
BR (1) BR0317519A (de)
CA (1) CA2507511A1 (de)
MX (1) MXPA05006771A (de)
NO (1) NO20053203L (de)
WO (1) WO2004058329A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060062836A1 (en) * 2004-09-21 2006-03-23 Carter Stephen G Methods of device-assisted drug delivery
PT1863469E (pt) 2005-03-15 2012-03-22 Animal Ethics Pty Ltd Composição anestésica tópica
ITMI20051633A1 (it) * 2005-09-06 2007-03-07 Sint Sa Nuovo uso di una composizione comprendente cloroprocaina hcl nuova composizione comprendente cloroprocaina hcl e metodo per la sua fabbricazione
AU2007275200A1 (en) * 2006-07-19 2008-01-24 Pharmacofore, Inc. Anesthetic compounds
WO2008051527A2 (en) * 2006-10-23 2008-05-02 Psivida, Inc. Sustained release of agents for localized pain management
US20110124685A1 (en) * 2008-01-18 2011-05-26 Jenkins Thomas E Anesthetic Compounds
ITMI20122120A1 (it) 2012-12-12 2014-06-13 Sint Sa Composizione farmaceutica a base di cloroprocaina per la somministrazione intratecale ripetuta
ITCR20130004A1 (it) * 2013-02-05 2014-08-06 Vincenzo Vigna Farmaco salvavita
US10117847B2 (en) 2015-12-04 2018-11-06 Ventis Pharma Extended duration local anesthetic formulation
DE102016215037A1 (de) 2016-08-11 2018-02-15 Franz Baur Federvorrichtung und Verbindungsvorrichtung
CN111163756B (zh) 2017-09-15 2022-04-15 辛苔蒂加股份有限公司 氯普鲁卡因的局部制剂
WO2019226599A1 (en) * 2018-05-22 2019-11-28 Alkalidx, Inc. Diagnostics and treatments of anesthetic insensitive subjects
JP6886551B1 (ja) * 2020-11-06 2021-06-16 医療法人祥和会 歯科用の局所麻酔液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US6326020B1 (en) * 1997-05-16 2001-12-04 Children's Medical Center Corporation Local anesthetic formulations
US7273887B1 (en) * 1999-10-22 2007-09-25 Transdermatech, Inc. Topical anesthetic formulation
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
AU2001231189A1 (en) * 2000-01-27 2001-08-07 Childrens Hospital Research Foundation Transdermal anesthetic and vasodilator composition and methods for topical administration

Also Published As

Publication number Publication date
WO2004058329A2 (en) 2004-07-15
NO20053203L (no) 2005-09-19
KR20050085736A (ko) 2005-08-29
MXPA05006771A (es) 2005-09-08
JP2006513224A (ja) 2006-04-20
AU2003299885A1 (en) 2004-07-22
NO20053203D0 (no) 2005-06-30
CN1729004A (zh) 2006-02-01
EP1572218A2 (de) 2005-09-14
BR0317519A (pt) 2005-11-16
EP1572218A4 (de) 2007-05-16
WO2004058329A3 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
US10576047B2 (en) Formulations for the treatment of pain
Buckenmaier et al. Anaesthetic agents for advanced regional anaesthesia: a North American perspective
Catterall et al. Local anesthetics
US8211887B2 (en) Topical preparation and method for transdermal delivery and localization of therapeutic agents
CA1118350A (en) Local anesthetic mixture for topical application, process for its preparation, as well as method for obtaining local anesthesia
EP2323645B1 (de) Verwendung niedrig-dosierter lokalanästhetika oder derivate davon zur therapie chronischer schmerzen, insbesondere migräne
CA2507511A1 (en) Ester combination local anesthetic
EP2349337A1 (de) Formulierungen zur behandlung von akuten schmerzen bei herpes zoster
US20050137177A1 (en) Ester combination local anesthetic
US20100041704A1 (en) Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus
WO2000030630A1 (en) Combination products of a guanylate cyclase inhibitor and a local anesthetic for pain relief
Cantisani et al. New patents on topical anesthetics
WO1993017674A1 (en) Topical use of local anaesthetic agents for rheumatoid arthritis as well as a pharmaceutical preparation and a method for the treatment thereof
Johnson Treatment of acute pain in cats
US9504666B2 (en) Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
Upadya et al. Anesthesia for dermatological surgery.
MAMA 12 LOCAL ANESTHETICS
Wolf et al. CHAPTER Local Anesthetic 96 Choice and Toxicity
Helgeson et al. Section 5 Local Anesthetics Chapter 64
Waechter et al. A comparison between topical and infiltrative bupivacaine and intravenous meperidine for postoperative analgesia after inguinal herniorrhaphy
Skarda et al. Local anesthetics and regional analgesic techniques
JPH0618787B2 (ja) 経皮吸収促進剤及びこれを用いた経皮吸収型製剤
Lambert Local anesthetic pharmacology
Glover et al. LOCAL ANESTHETICS
Patil A Clinical Comparision Between 0.5% Bupivacaine and 0.5% Bupivacaine Dexamethasone 8mg Combination in Brachial Plexus Block by Supraclavicular Approach

Legal Events

Date Code Title Description
FZDE Discontinued